NO922226L - 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater - Google Patents

7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater

Info

Publication number
NO922226L
NO922226L NO92922226A NO922226A NO922226L NO 922226 L NO922226 L NO 922226L NO 92922226 A NO92922226 A NO 92922226A NO 922226 A NO922226 A NO 922226A NO 922226 L NO922226 L NO 922226L
Authority
NO
Norway
Prior art keywords
carboxylic acid
acid derivatives
navythyridon
quinolon
isoindolinyl
Prior art date
Application number
NO92922226A
Other languages
English (en)
Norwegian (no)
Other versions
NO922226D0 (no
Inventor
Uwe Petersen
Andreas Krebs
Thomas Schenke
Franz Kunisch
Thomas Philipps
Klaus Grohe
Klaus-Dieter Bremm
Rainer Endermann
Karl-Georg Metzger
Ingo Haller
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO922226D0 publication Critical patent/NO922226D0/no
Publication of NO922226L publication Critical patent/NO922226L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO92922226A 1991-06-22 1992-06-05 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater NO922226L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120646A DE4120646A1 (de) 1991-06-22 1991-06-22 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate

Publications (2)

Publication Number Publication Date
NO922226D0 NO922226D0 (no) 1992-06-05
NO922226L true NO922226L (no) 1992-12-23

Family

ID=6434522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922226A NO922226L (no) 1991-06-22 1992-06-05 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater

Country Status (20)

Country Link
US (1) US5464796A (en, 2012)
EP (1) EP0520240A1 (en, 2012)
JP (1) JPH05239051A (en, 2012)
KR (1) KR930000503A (en, 2012)
CN (1) CN1068115A (en, 2012)
AU (1) AU648669B2 (en, 2012)
CA (1) CA2071677A1 (en, 2012)
CZ (1) CZ190192A3 (en, 2012)
DE (1) DE4120646A1 (en, 2012)
FI (1) FI922873A7 (en, 2012)
HU (1) HUT62288A (en, 2012)
IE (1) IE922003A1 (en, 2012)
IL (1) IL102261A (en, 2012)
MX (1) MX9202982A (en, 2012)
NO (1) NO922226L (en, 2012)
NZ (1) NZ243214A (en, 2012)
PH (1) PH30227A (en, 2012)
RU (1) RU2056411C1 (en, 2012)
SK (1) SK190192A3 (en, 2012)
TW (1) TW202442B (en, 2012)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19500792A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DE19506535A1 (de) * 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
CN1264837C (zh) * 1997-09-15 2006-07-19 普罗克特和甘保尔公司 喹诺酮抗微生物剂、其组合物和应用
PA8466701A1 (es) 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
SE9801474D0 (sv) * 1998-04-27 1998-04-27 Active Biotech Ab Quinoline Derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
ID28795A (id) * 1998-11-24 2001-07-05 Daiichi Seiyaku Co Turunan aminometilpirolidina tersubstitusi sikloalkil
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
RU2297420C2 (ru) * 2000-02-09 2007-04-20 Дайити Фармасьютикал Ко., Лтд. Средство против кислотоустойчивых бактерий, содержащее гетероциклические производные бензоксазина в качестве активного компонента
US7304075B2 (en) * 2000-04-24 2007-12-04 Daiichi Pharmaceutical Co., Ltd. Stabilized liquid preparation
US7220824B1 (en) 2000-08-28 2007-05-22 Bayer Aktiengesellschaft Integrin-mediated drug targeting
EP1219634A1 (en) * 2000-12-27 2002-07-03 Bayer Aktiengesellschaft Cytostatic-glycoconjugates having specifically cleavable peptidic linking units
PL367285A1 (en) * 2001-02-21 2005-02-21 Zentaris Gmbh Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
EP1238678A1 (en) 2001-03-08 2002-09-11 Bayer Aktiengesellschaft Enzyme-activated cytostatic conjugates with integrin ligands
RU2275361C3 (ru) * 2002-11-20 2021-10-01 Джапан Тобакко Инк. Соединение 4-оксохинолина и его применение в качестве ингибитора вич интегразы
NZ592897A (en) * 2005-10-19 2012-12-21 Teva Pharma Crystals of laquinimod sodium, and process for the manufacture thereof
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
SI2001862T1 (sl) * 2006-03-28 2011-10-28 Warner Chilcott Co Llc Soli malatov in polimorfi (3S, 5S)-7-(3-amino-5-metil-piperidinil)-1-ciklopropil-1,4-dihidro-8-metoksi- 4-okso-3-kinolinkarboksline kisline
KR20110082635A (ko) * 2006-03-28 2011-07-19 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
RU2399616C1 (ru) * 2006-06-23 2010-09-20 Джапан Тобакко Инк. Производное 6-(гетероциклзамещенный бензил)-4-оксохинолина и его применение в качестве ингибитора интегразы вич
KR100690084B1 (ko) * 2006-11-01 2007-03-09 주식회사 세홍이엔씨 출입문과 연동하는 주택 내 배전반
USD612227S1 (en) 2009-02-06 2010-03-23 Rockler Companies, Inc. Workpiece finishing support
WO2013111158A2 (en) * 2012-01-03 2013-08-01 Msn Laboratories Limited Process for the preparation of dpp-iv inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
DE3577089D1 (de) * 1984-01-26 1990-05-17 Abbott Lab Antibakterielle chinolinderivate.
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
AU5404790A (en) * 1989-04-26 1990-11-16 Upjohn Company, The Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines

Also Published As

Publication number Publication date
DE4120646A1 (de) 1992-12-24
MX9202982A (es) 1992-12-01
HUT62288A (en) 1993-04-28
KR930000503A (ko) 1993-01-15
HU9202085D0 (en) 1992-09-28
TW202442B (en, 2012) 1993-03-21
NO922226D0 (no) 1992-06-05
AU1739192A (en) 1992-12-24
IL102261A0 (en) 1993-01-14
PH30227A (en) 1997-02-05
AU648669B2 (en) 1994-04-28
CA2071677A1 (en) 1992-12-23
NZ243214A (en) 1995-07-26
CZ190192A3 (en) 1993-01-13
IL102261A (en) 1996-10-16
RU2056411C1 (ru) 1996-03-20
EP0520240A1 (de) 1992-12-30
JPH05239051A (ja) 1993-09-17
SK190192A3 (en) 1995-08-09
CN1068115A (zh) 1993-01-20
US5464796A (en) 1995-11-07
FI922873A0 (fi) 1992-06-18
FI922873A7 (fi) 1992-12-23
IE922003A1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
NO922226L (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
EE9900248A (et) 7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe- ja -naftüridoonkarboksüülhappederivaatide kasutamine Helicobacter pylori infektsioonide ja sellega assotsieeruvate gastroduodenaalhaiguste teraapiaks
FI873248A0 (fi) 7-((3-(aminometyl)-3-alkyl)-1 -pyrrolidinyl)-kinolin-karboxylsyror.
AU6307586A (en) Quinoline derivatives
ES2126684T3 (es) Utilizacion de derivados de acidos carboxilicos aromaticos para la preparacion de medicamentos.
AU1835988A (en) New derivatives of substituted pyridine-3-carboxylic acid and use thereof
ES544752A0 (es) Un procedimiento para la preparacion de carbapenems.
SE7810295L (sv) Substituerad kinolinkarboxylsyra
SE8001689L (sv) 6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
CA2107675A1 (en) Antibiotic carbapenem derivatives
NO824304L (no) Fremgangsmaate for fremstilling av antibakterielle pencillinderivater
DE3650221D1 (de) Penemderivate.
AU562643B2 (en) N-arylpiperazine derivatives
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
YU12191A (sh) Kristalni hidrohlorid novog beta-laktamskog antibiotika i postupak za njegovo dobijanje
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
ES2010462A6 (es) Procedimiento para obtener ciprofloxacina.
GB1449159A (en) Benzoisoindoline derivatives
ES2009936A6 (es) Procedimiento para obtener ciprofloxacina.